Your session is about to expire
← Back to Search
Behavioural Intervention
INTACT Program for Alzheimer's Disease (INTACT Trial)
N/A
Recruiting
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients must be age 55 or older at the start of the surveillance interval
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12-month follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if training healthcare providers and creating dementia-friendly clinics can help in identifying and managing Alzheimer's and related dementias in American Indian and Alaska Native patients in 28 urban and rural clinics
Who is the study for?
This trial is for healthcare providers in clinics serving American Indian/Alaska Native (AI/AN) communities. It aims to improve the detection and management of Alzheimer's Disease and related dementias (ADRD) as well as mild cognitive impairment (MCI).
What is being tested?
The INTACT Program is being tested, which involves training providers and transforming clinics into 'dementia friendly' environments. The effectiveness will be measured across 28 urban and rural AI/AN-serving clinics.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 55 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 12-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12-month follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinic Level - new diagnoses of ADRD and MCI (Aim 2)
PCP level - care confidence (Aim 1)
Patient level - quality of care 1 (Aim 3)
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: WaitlistExperimental Treatment1 Intervention
The INTACT Program has three components:
1. provide a training for Primary Care Providers (PCPs) training in screening, diagnosis, and care for ADRD,
2. at the PCP level, provide quarterly webinars. Topics will address driving and dementia; communication tips for someone with dementia; eating and drinking in advanced dementia; and advanced care planning for dementia.
3. At the clinic level, provide a workflow model for cognitive evaluation and setting a plan for the newly diagnosed patient. The INTACT intervention lasts 12 months and Continuing Medical Education credits will be available to PCPs who complete the INTACT training program
Group II: InterventionExperimental Treatment1 Intervention
The INTACT Program has three components:
1. provide a training for Primary Care Providers (PCPs) training in screening, diagnosis, and care for ADRD,
2. at the PCP level, provide quarterly webinars. Topics will address driving and dementia; communication tips for someone with dementia; eating and drinking in advanced dementia; and advanced care planning for dementia.
3. At the clinic level, provide a workflow model for cognitive evaluation and setting a plan for the newly diagnosed patient. The INTACT intervention lasts 12 months and Continuing Medical Education credits will be available to PCPs who complete the INTACT training program
Find a Location
Who is running the clinical trial?
Washington State UniversityLead Sponsor
109 Previous Clinical Trials
57,643 Total Patients Enrolled
University of MiamiOTHER
955 Previous Clinical Trials
428,820 Total Patients Enrolled
University of WashingtonOTHER
1,831 Previous Clinical Trials
1,907,541 Total Patients Enrolled
University of MinnesotaOTHER
1,439 Previous Clinical Trials
1,621,930 Total Patients Enrolled